Portfolio company
Sable Bio
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
Deep TechB2B SaaS
About
This company develops a drug safety intelligence platform for toxicologists and scientists to evaluate biological targets during the early stages of drug discovery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.